, United States
-
Journal of the ASEAN Federation of Endocrine Societies Early Access Articles - Review Articles
Interrelationship of Sarcopenia and Cardiovascular Diseases
Abstract PDF -
Journal of the ASEAN Federation of Endocrine Societies Early Access Articles - Review Articles
The Roles of Non-Pharmacologic and Emerging Pharmacologic Management of Non-alcoholic Fatty Liver Disease and Sarcopenia
Abstract PDF -
Journal of the ASEAN Federation of Endocrine Societies Vol. 27 No. 1 (2012): May Issue - Feature Articles
The Immunology of Autoimmune Thyroid Disease in Pregnancy
Abstract Abstract HTML PDF -
Journal of the ASEAN Federation of Endocrine Societies Vol. 27 No. 2 (2012): November Issue - Feature Articles
Diabetic Retinopathy in Southeast Asia: A Call for Ocular Telehealth Programs
Abstract Abstract HTML PDF -
Journal of the ASEAN Federation of Endocrine Societies Vol. 33 No. 1 (2018): May Issue - Author Guidelines
Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals
Abstract PDF -
Journal of the ASEAN Federation of Endocrine Societies Vol. 34 No. 2 (2019): November Issue - Feature Articles
Engaging the ASEAN Diaspora: Type 2 Diabetes Prevalence, Pathophysiology, and Unique Risk Factors among Filipino Migrants in the United States
Abstract Abstract HTML PDF -
Journal of the ASEAN Federation of Endocrine Societies Vol. 34 No. 2 (2019): AFES Book of Abstracts (Supplement) - Oral Research Presentations
GLYCEMIC CONTROL AND COGNITIVE FUNCTION AFTER 50 YEARS OF TYPE 1 DIABETES
Abstract PDF -
Journal of the ASEAN Federation of Endocrine Societies Vol. 34 No. 2 (2019): AFES Book of Abstracts (Supplement) - Oral Research Presentations
LIRAGLUTIDE 3.0 mg AS AN ADJUNCT TO INTENSIVE BEHAVIOR THERAPY IN INDIVIDUALS WITH OBESITY
Abstract PDF -
Journal of the ASEAN Federation of Endocrine Societies Vol. 34 No. 2 (2019): AFES Book of Abstracts (Supplement) - Oral Research Presentations
EFFICACY AND SAFETY OF LIRAGLUTIDE 3.0 mg IN INDIVIDUALS WITH OVERWEIGHT OR OBESITY AND TYPE 2 DIABETES (T2D) TREATED WITH BASAL INSULIN
Abstract PDF -
Journal of the ASEAN Federation of Endocrine Societies Vol. 34 No. 2 (2019): AFES Book of Abstracts (Supplement) - Abstracts of Original Articles | General Endocrinology
WEIGHT LOSS WITH LIRAGLUTIDE 3.0 mg VERSUS PLACEBO FOR INDIVIDUALS WHO ADHERE TO THE TRIAL DRUG
Abstract PDF -
Journal of the ASEAN Federation of Endocrine Societies Vol. 34 No. 2 (2019): AFES Book of Abstracts (Supplement) - Abstracts of Original Articles | General Endocrinology
EARLY RESPONDERS TO LIRAGLUTIDE 3.0 mg AS ADJUNCT TO DIET+EXERCISE FROM THE SCALE MAINTENANCE TRIAL
Abstract PDF -
Journal of the ASEAN Federation of Endocrine Societies Vol. 34 No. 2 (2019): AFES Book of Abstracts (Supplement) - Abstracts of Original Articles | General Endocrinology
OUTCOMES IN EARLY RESPONDERS ACHIEVING ≥5% WEIGHT LOSS AT 16 WEEKS WITH LIRAGLUTIDE 3.0 mg AS AN ADJUNCT TO INTENSIVE BEHAVIOUR THERAPY (IBT) IN INDIVIDUALS WITH OBESITY IN THE SCALE IBT TRIAL
Abstract PDF -
Journal of the ASEAN Federation of Endocrine Societies Vol. 34 No. 2 (2019): AFES Book of Abstracts (Supplement) - Oral Research Presentations
ROLE OF HYPOXIA-INDUCIBLE FACTOR 1A (HIF1A) ON INTERMITTENT HYPOXIAINDUCED ADIPOSE TISSUE DYSFUNCTION IN TYPE 2 DIABETES MELLITUS
Abstract PDF